James Tobin
Angel · Utah
Board director at 2 startups that filed Form D raises since late 2024, mostly in Utah.
- Stages
- Series B
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Jun 2023
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: XenterJan 6, 2023
- SEC Form D: Lyra TherapeuticsJun 9, 2023
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.